Structural determinants of the eosinophil cationic protein antimicrobial activity

Biological Chemistry

Volumn 393, Issue 8, 2012, Pages 801-815

  Boix, Ester ^a   Salazar, Vivian A ^a   Torrent, Marc ^a   Pulido, David ^a   Nogués, M Victòria ^a   Moussaoui, Mohammed ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Bactericidal; Glycosaminoglycans; Host defence; Innate immunity; Nucleotides; RNase

Indexed keywords

ANTIPARASITIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; EOSINOPHIL CATIONIC PROTEIN; NUCLEOTIDE BINDING PROTEIN; RIBONUCLEASE; RIBONUCLEASE 1; RIBONUCLEASE 4; RIBONUCLEASE 5; RIBONUCLEASE 6; RIBONUCLEASE 7; RIBONUCLEASE 8; RIBONUCLEASE II; RIBONUCLEASE III; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; BINDING AFFINITY; BRUGIA MALAYI; CELL AGGLUTINATION; CYTOTOXICITY; ENTEROCOCCUS FAECIUM; ENZYME ACTIVE SITE; ESCHERICHIA COLI; HOST RESISTANCE; HUMAN; LEISHMANIA; MALARIA FALCIPARUM; MEMBRANE BINDING; MICROCOCCUS LUTEUS; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PEPTIDE SYNTHESIS; PLASMODIUM FALCIPARUM; PREDICTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SITE DIRECTED MUTAGENESIS; STAPHYLOCOCCUS AUREUS; TRYPANOSOMA;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; EOSINOPHIL CATIONIC PROTEIN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 84862259963     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0160     Document Type: Review

References (118)

1. Abtin, A., Eckhart, L., Mildner, M., Ghannadan, M., Harder, J., Schroder, J.M., and Tschachler, E. (2009). Degradation by stratum corneum proteases prevents endogenous rnase inhibitor from blocking antimicrobial activities of RNase 5 and RNase 7. J. Invest. Dermatol. 129, 2193 -2201.
2. Ackerman, S.J., Gleich, G.J., Loegering, D.A., Richardson, B.A., and Butterworth, A.E. (1985). Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 34, 735 -745.
3. Adu, B., Dodoo, D., Adukpo, S., Gyan, B.A., Hedley, P.L., Goka, B., Adjei, G.O., Larsen, S.O., Christiansen, M., and Theisen, M. (2011). Polymorphisms in the RNASE3 gene are associated with susceptibility to cerebral malaria in Ghanaian children. PLoS One 6, e29465.
4. Ashitani, J., Yanagi, S., Arimura, Y., Sano, A., and Mukae, H. (2003). Acute respiratory distress syndrome induced by rifampicin with high levels of neutrophil and eosinophil products in bronchoalveolar lavage fluid. Respiration 70, 541 -543.
5. Ayabe, T., Satchell, D.P., Pesendorfer, P., Tanabe, H., Wilson, C.L., Hagen, S.J., and Ouellette, A.J. (2002). Activation of Paneth cell α -defensins in mouse small intestine. J. Biol. Chem. 277, 5219 -5228.
6. Baker, M.D., Holloway, D.E., Swaminathan, G.J., and Acharya, K.R. (2006). Crystal structures of eosinophil-derived neurotoxin (EDN) in complex with the inhibitors 5′ -ATP, Ap3A, Ap4A, and Ap5A. Biochemistry 45, 416 -426.
7. Beintema, J.J. and Kleineidam, R.G. (1998). The ribonuclease A superfamily: general discussion. Cell. Mol. Life Sci. 54, 825 -832.
8. Beintema, J.J., Blank, A., Schieven, G.L., Dekker, C.A., Sorrentino, S., and Libonati, M. (1988). Differences in glycosylation pattern of human secretory ribonucleases. Biochem. J. 255, 501 -505.
9. Blanchard, C. and Rothenberg, M.E. (2009). Biology of the Eosinophil. Adv. Immunol. 101, 81 -121.
10. Boix, E. and Nogues, M.V. (2007). Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence. Mol. Biosyst. 3, 317 -335.
11. Boix, E., Torrent, M., Sánchez, D., and Nogués, M.V. (2008). The antipathogen activities of eosinophil cationic protein. Curr. Pharm. Biotechnol. 9, 141 -152.
12. Boix, E., Torrent, M., Nogués, M., and Salazar, V. (2011). Searching for heparin binding patterns. In: Heparin: Properties, Uses and Side Effects. E.D. Piyathilake and R. Liang, ed. (NY, USA: Nova Sciences Publishers, Inc).
13. Boix, E., Pulido, D., Moussaoui, M., Nogues, M.V., and Russi, S. (2012). The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form. J. Struct. Biol., in press.
14. Brandenburg, K., Andra, J., Garidel, P., and Gutsmann, T. (2011). Peptide-based treatment of sepsis. Appl. Microbiol. Biotechnol. 90, 799 -808.
15. Burton, M.F. and Steel, P.G. (2009). The chemistry and biology of LL-37. Nat. Prod. Rep. 26, 1572 -1584.
16. Bystrom, J., Amin, K., and Bishop-Bailey, D. (2011). Analysing the eosinophil cationic protein -a clue to the function of the eosinophil granulocyte. Respir. Res. 12, 10.
17. Capila, I. and Linhardt, R.J. (2002). Heparin-protein interactions. Angew. Chem. Int. Ed. 41, 391 -412.
18. Carreras, E., Boix, E., Rosenberg, H.F., Cuchillo, C.M., and Nogues, M.V. (2003). Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. Biochemistry 42, 6636 -6644.
19. Carreras, E., Boix, E., Navarro, S., Rosenberg, H.F., Cuchillo, C.M., and Nogues, M.V. (2005). Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation. Mol. Cell. Biochem. 272, 1 -7.
20. Chan, C.C., Moser, J.M., Dyer, K.D., Percopo, C.M., and Rosenberg, H.F. (2012). Genetic diversity of human RNase 8. BMC Genomics 13, 40.
21. Cho, S., Beintema, J.J., and Zhang, J. (2005). The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85, 208 -220.
22. Cho, S. and Zhang, J. (2007). Zebrafish ribonucleases are bactericidal: implications for the origin of the vertebrate RNase A superfamily. Mol. Biol. Evol. 24, 1259 -1268.
23. Clark, H.F., Gurney, A.L., Abaya, E., Baker, K., Baldwin, D., Brush, J., Chen, J., Chow, B., Chui, C., Crowley, C., et al. (2003). The Secreted Protein Discovery Initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 13, 2265 -2270.
24. Conchillo-Sole, O., de Groot, N.S., Aviles, F.X., Vendrell, J., Daura, X., and Ventura, S. (2007). AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8, 65.
25. Cuchillo, C.M., Nogues, M.V., and Raines, R.T. (2011). Bovine pancreatic ribonuclease: fifty years of the first enzymatic reaction mechanism. Biochemistry 50, 7835 -7841.
26. During, K., Porsch, P., Mahn, A., Brinkmann, O., and Gieffers, W. (1999). The non-enzymatic microbicidal activity of lysozymes. FEBS Lett. 449, 93 -100.
27. Dyer, K.D., Rosenberg, H.F., and Zhang, J.Z. (2004). Isolation, characterization, and evolutionary divergence of mouse RNase 6: evidence for unusual evolution in rodents. J. Mol. Evol. 59, 657-665.
28. Elshafie, A.I., Ahlin, E., Hakansson, L.D., Elghazali, G., El Safi, S.H., Ronnelid, J., and Venge, P. (2011). Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis. Int. J. Parasitol. 41, 463 -469.
29. Eriksson, J., Reimert, C.M., Kabatereine, N.B., Kazibwe, F., Ireri, E., Kadzo, H., Eltahir, H.B., Mohamed, A.O., Vennervald, B.J., and Venge, P. (2007a). The 434(G > C) polymorphism within the coding sequence of Eosinophil Cationic Protein (ECP) correlates with the natural course of Schistosoma mansoni infection. Int. J. Parasitol. 37, 1359 -1366.
30. Eriksson, J., Woschnagg, C., Fernvik, E., and Venge, P. (2007b). A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein. J. Leukoc. Biol. 82, 1491 -1500.
31. Fan, T.C., Chang, H.T., Chen, I.W., Wang, H.Y., and Chang, M.D. (2007). A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic 8, 1778 -1795.
32. Fan, T.C., Fang, S.L., Hwang, C.S., Hsu, C.Y., Lu, X.A., Hung, S.C., Lin, S.C., and Chang, D.T. (2008). Characterization of molecular interactions between eosinophil cationic protein and heparin. J. Biol. Chem. 283, 25468 -25474.
33. Fontecilla-Camps, J.C., de Llorens, R., le Du, M.H., and Cuchillo, C.M. (1994). Crystal structure of ribonuclease A.d(ApTpApApG) complex. Direct evidence for extended substrate recognition. J. Biol. Chem. 269, 21526 -21531.
34. Frecer, V., Ho, B., and Ding, J.L. (2004). De novo design of potent antimicrobial peptides. Antimicrob. Agents Chemother. 48, 3349 -3357.
35. Fuchs, S.M. and Raines, R.T. (2006). Internalization of cationic peptides: the road less (or more ?) traveled. Cell. Mol. Life Sci. 63, 1819 -1822.
36. Gabay, J.E., Scott, R.W., Campanelli, D., Griffith, J., Wilde, C., Marra, M.N., Seeger, M., and Nathan, C.F. (1989). Antibiotic proteins of human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 86, 5610 -5614.
37. Gao, X.W. and Xu, Z.P. (2008). Mechanisms of action of angiogenin. Acta Biochim. Biophys. Sin. 40, 619 -624.
38. Garc í a-Mayoral, M.F., Moussaoui, M., de la Torre, B.G., Andreu, D., Boix, E., Nogués, M.V., Rico, M., Laurents, D.V., and Bruix, M. (2010). NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics. Biophys. J. 98, 2702 -2711.
39. Giancola, C., Ercole, C., Fotticchia, I., Spadaccini, R., Pizzo, E., D'Alessio, G., and Picone, D. (2011). Structure-cytotoxicity relationships in bovine seminal ribonuclease: new insights from heat and chemical denaturation studies on variants. FEBS J. 278, 111 -122.
40. Gleich, G.J., Loegering, D.A., Bell, M.P., Checkel, J.L., Ackerman, S.J., and McKean, D.J. (1986). Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc. Natl. Acad. Sci. USA 83, 3146 -3150.
41. Greenway, M.J., Andersen, P.M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006). ANG mutations segregate with familial and'sporadic'amyotrophic lateral sclerosis. Nat. Genet. 38, 411 -413.
42. Gutsmann, T., Razquin-Olazaran, I., Kowalski, I., Kaconis, Y., Howe, J., Bartels, R., Hornef, M., Schurholz, T., Rossle, M., Sanchez-Gomez, S., et al. (2010). New antiseptic peptides to protect against endotoxin-mediated shock. Antimicrob. Agents Chemother. 54, 3817 -3824.
43. Hamann, K.J., Gleich, G.J., Checkel, J.L., Loegering, D.A., McCall, J.W., and Barker, R.L. (1990). In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. J. Immunol. 144, 3166 -3173.
44. Harder, J. and Schroder, J.M. (2002). RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277, 46779 -46784.
45. Hofsteenge, J., Vicentini, A., and Zelenko, O. (1998). Ribonuclease 4, an evolutionarily highly conserved member of the superfamily. Cell. Mol. Life Sci. 54, 804 -810.
46. Hooper, L.V., Stappenbeck, T.S., Hong, C.V., and Gordon, J.I. (2003). Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269 -273.
47. Imberty, A., Lortat-Jacob, H., and Perez, S. (2007). Structural view of glycosaminoglycan-protein interactions. Carbohydr. Res. 342, 430 -439.
48. Kaconis, Y., Kowalski, I., Howe, J., Brauser, A., Richter, W., Razquin-Olazaran, I., Inigo-Pestana, M., Garidel, P., Rossle, M., de Tejada, G.M., et al. (2011). Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. Biophys. J. 100, 2652 -2661.
49. Karawajczyk, M., Pauksen, K., Peterson, C.G.B., Eklund, E., and Venge, P. (1995). The differential release of eosinophil granule proteins-studies on patients with acute bacterial and viral infections. Clin. Exp. Allergy 25, 713 -719.
50. Kierszenbaum, F., Villalta, F., and Tai, P.C. (1986). Role of inflammatory cells in Chagas'disease .3. Kinetics of human eosinophil activation upon interaction with parasites (Trypanosoma cruzi). J. Immunol. 136, 662 -666.
51. Klion, A.D. and Nutman, T.B. (2004). The role of eosinophils in host defense against helminth parasites. J. Allergy Clin. Immunol. 113, 30 -37.
52. Krieg, J., Hartmann, S., Vicentini, A., Glasner, W., Hess, D., and Hofsteenge, J. (1998). Recognition signal for C-mannosylation of Trp-7 in RNase 2 consists of sequence Trp-x-x-Trp. Mol. Biol. Cell 9, 301 -309.
53. Kristjansson, S., Bjarnarson, S.P., Wennergren, G.E., Palsdottir, A.H., Arnadottir, T., Haraidsson, A., and Jonsdottir, I. (2005). Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local T(H)2-like response. J. Allergy Clin. Immunol. 116, 805 -811.
54. Kurtzhals, J.A.L., Reimert, C.M., Tette, E., Dunyo, S.K., Koram, K.A., Akanmori, B.D., Nkrumah, F.K., and Hviid, L. (1998). Increased eosinophil activity in acute Plasmodium falciparum infection -association with cerebral malaria. Clin. Exp. Immunol. 112, 303 -307.
55. Kvarnhammar, A.M. and Cardell, L.O. (2012). Pattern-recognition receptors in human eosinophils. Immunology 136, 11 -20.
56. Lehrer, R.I., Szklarek, D., Barton, A., Ganz, T., Hamann, K.J., and Gleich, G.J. (1989). Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J. Immunol. 142, 4428 -4434.
57. Leonidas, D.D., Boix, E., Prill, R., Suzuki, M., Turton, R., Minson, K., Swaminathan, G.J., Youle, R.J., and Acharya, K.R. (2001). Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors. J. Biol. Chem. 276, 15009 -15017.
58. Levy, O. (2000). Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96, 2664 -2672.
59. Lortat-Jacob, H., Grosdidier, A., and Imberty, A. (2002). Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. USA 99, 1229 -1234.
60. Makepeace, B.L., Martin, C., Turner, J.D., and Specht, S. (2012). Granulocytes in helminth infection-who is calling the shots ? Curr. Med. Chem. 19, 1567 -1586.
61. Malik, A. and Batra, J.K. (2012). Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens. Crit. Rev. Microbiol. 38, 168 -181.
62. Masschalck, B., Van Houdt, R., Van Haver, E.G.R., and Michiels, C.W. (2001). Inactivation of gram-negative bacteria by lysozyme, denatured lysozyme, and lysozyme-derived peptides under high hydrostatic pressure. Appl. Environ. Microbiol. 67, 339 -344.
63. Mclaren, D.J., Peterson, C.G.B., and Venge, P. (1984). Schistosoma mansoni -further studies of the interaction between schistosomula and granulocyte-derived cationic proteins in vitro. Parasitology 88, 491 -503.
64. Moenner, M., Gusse, M., Hatzi, E., and Badet, J. (1994). The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur. J. Biochem. 226, 483 -490.
65. Mohan, C.G., Boix, E., Evans, H.R., Nikolovski, Z., Nogues, M.V., Cuchillo, C.M., and Acharya, K.R. (2002). The crystal structure of eosinophil cationic protein in complex with 2 ′, 5 ′ -ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site. Biochemistry 41, 12100 -12106.
66. Monteseirin, J., Vega, A., Chacon, P., Camacho, M.J., El Bekay, R., Asturias, J.A., Martinez, A., Guardia, P., Perez-Cano, R., and Conde, J. (2007). Neutrophils as a novel source of eosinophil cationic protein in IgE-mediated processes. J. Immunol. 179, 2634 -2641.
67. Mosimann, S.C., Newton, D.L., Youle, R.J., and James, M.N. (1996). X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 Å resolution. J. Mol. Biol. 260, 540 -552.
68. Nakatsuji, T. and Gallo, R.L. (2012). Antimicrobial peptides: old molecules with new ideas. J. Invest. Dermatol. 132, 887 -895.
69. Navarro, S., Aleu, J., Jimenez, M., Boix, E., Cuchillo, C.M., and Nogues, M.V. (2008). The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Cell. Mol. Life Sci. 65, 324 -337.
70. Navarro, S., Boix, E., Cuchillo, C.M., and Nogues, M.V. (2010). Eosinophil-induced neurotoxicity: the role of eosinophil cationic protein/RNase 3. J. Neuroimmunol. 227, 60 -70.
71. Nibbering, P.H., Ravensbergen, E., Welling, M.M., van Berkel, L.A., van Berkel, P.H., Pauwels, E.K., and Nuijens, J.H. (2001). Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69, 1469 -1476.
72. Niehaus, M.D., Gwaltney, J.M., Hendley, J.O., Newman, M.J., Heymann, P.W., Rakes, G.P., Platts-Mills, T.A.E., and Guerrant, R.L. (2000). Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis. J. Clin. Microbiol. 38, 3100 -3102.
73. Nitto, T., Dyer, K.D., Czapiga, M., and Rosenberg, H.F. (2006). Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus. J. Biol. Chem. 281, 25622 -25634.
74. Nogues, M.V., Moussaoui, M., Boix, E., Vilanova, M., Ribo, M., and Cuchillo, C.M. (1998). The contribution of noncatalytic phosphate-binding subsites to the mechanism of bovine pancreatic ribonuclease A. Cell. Mol. Life Sci. 54, 766 -774.
75. Pizzo, E. and D'Alessio, G. (2007). The success of the RNase scaffold in the advance of biosciences and in evolution. Gene 406, 8 -12.
76. Pizzo, E., Varcamonti, M., Di Maro, A., Zanfardino, A., Giancola, C., and D'Alessio, G. (2008). Ribonucleases with angiogenic and bactericidal activities from the Atlantic salmon. FEBS J. 275, 1283 -1295.
77. Pulido, D., Moussaoui, M., Andreu, D., Nogués, M., Torrent, M., and Boix, E. (2012). Antimicrobial action and cell agglutination by eosinophil cationic protein is modulated by the cell wall lipopolysaccharide structure. Antimicrob. Agents Chemother. 56, 2378 -2385.
78. Raines, R.T. (1998). Ribonuclease A. Chem. Rev. 98, 1045 -1066.
79. Rosenberg, H.F. (1995). Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J. Biol. Chem. 270, 7876 -7881.
80. Rosenberg, H.F. (2008a). Eosinophil-derived neurotoxin/RNase 2: connecting the past, the present and the future. Curr. Pharm. Biotechnol. 9, 135 -140.
81. Rosenberg, H.F. (2008b). RNase A ribonucleases and host defense: an evolving story. J. Leukoc. Biol. 83, 1079 -1087.
82. Rosenberg, H.F. and Dyer, K.D. (1996). Molecular cloning and characterization of a novel human ribonuclease (RNase k6): increasing diversity in the enlarging ribonuclease gene family. Nucleic Acids Res. 24, 3507 -3513.
83. Rosenberg, H.F., Dyer, K.D., Tiffany, H.L., and Gonzalez, M. (1995). Rapid evolution of a unique family of primate ribonuclease genes. Nat. Genet. 10, 219 -223.
84. Rubin, J., Zagai, U., Blom, K., Trulson, A., Engstrom, A., and Venge, P. (2009). The coding ECP 434(G > C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity. J. Immunol. 183, 445 -451.
85. Rudolph, B., Podschun, R., Sahly, H., Schubert, S., Schroder, J.M., and Harder, J. (2006). Identification of RNase 8 as a novel human antimicrobial protein. Antimicrob. Agents Chemother. 50, 3194 -3196.
86. Sanchez, D., Moussaoui, M., Carreras, E., Torrent, M., Nogues, V., and Boix, E. (2011). Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage. Biochimie 93, 331 -338.
87. Schroeder, B.O., Wu, Z.H., Nuding, S., Groscurth, S., Marcinowski, M., Beisner, J., Buchner, J., Schaller, M., Stange, E.F., and Wehkamp, J. (2011). Reduction of disulphide bonds unmasks potent antimicrobial activity of human β -defensin 1. Nature 469, 419 -423.
88. Sikriwal, D., Seth, D., Dey, P., and Batra, J.K. (2007). Human eosinophil-derived neurotoxin: involvement of a putative noncatalytic phosphate-binding subsite in its catalysis. Mol. Cell. Biochem. 303, 175 -181.
89. Sikriwal, D., Seth, D., and Batra, J.K. (2009). Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin. Biol. Chem. 390, 225 -234.
90. Simanski, M., Köten, B., Schröder, J.M., Gläser, R., and Harder, J. (2012). Antimicrobial RNases in cutaneous defense. J. Innate Immun. 4, 241 -247.
91. Singh, A. and Batra, J.K. (2011). Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein. Biol. Chem. 392, 337 -346.
92. Sorrentino, S. (2010). The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins. FEBS Lett. 584, 2194 -2200.
93. Spencer, J.D., Schwaderer, A.L., DiRosario, J.D., McHugh, K.M., McGillivary, G., Justice, S.S., Carpenter, A.R., Baker, P.B., Harder, J., and Hains, D.S. (2011). Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int. 80, 175 -181.
94. Strydom, D.J. (1998). The angiogenins. Cell. Mol. Life Sci. 54, 811 -824.
95. Strydom, D.J., Fett, J.W., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F., and Vallee, B.L. (1985). Amino-acid sequence of human-tumor derived angiogenin. Biochemistry 24, 5486 -5494.
96. Swaminathan, G.J., Holloway, D.E., Veluraja, K., and Acharya, K.R. (2002). Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin. Biochemistry 41, 3341 -3352.
97. Tischendorf, F.W., Brattig, N.W., Buttner, D.W., Pieper, A., and Lintzel, M. (1996). Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes. Acta Trop. 62, 171 -182.
98. Torrent, M., Cuyas, E., Carreras, E., Navarro, S., Lopez, O., de la Maza, A., Nogues, M.V., Reshetnyak, Y.K., and Boix, E. (2007). Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. Biochemistry 46, 720 -733.
99. Torrent, M., Navarro, S., Moussaoui, M., Nogues, M.V., and Boix, E. (2008). Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry 47, 3544 -3555.
100. Torrent, G., Ribo, M., Benito, A., and Vilanova, M. (2009a). Bactericidal activity engineered on human pancreatic ribonuclease and onconase. Mol. Pharm. 6, 531 -542.
101. Torrent, M., de la Torre, B.G., Nogues, V.M., Andreu, D., and Boix, E. (2009b). Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem. J. 421, 425 -434.
102. Torrent, M., Badia, M., Moussaoui, M., Sanchez, D., Nogues, M.V., and Boix, E. (2010a). Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall. FEBS J. 277, 1713 -1725.
103. Torrent, M., Odorizzi, F., Nogues, M.V., and Boix, E. (2010b). Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region. Biomacromolecules 11, 1983 -1990.
104. Torrent, M., Nogues, M.V., and Boix, E. (2011a). Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site. J. Mol. Recognit. 24, 90 -100.
105. Torrent, M., Pulido, D., De la Torre, B.G., Garcia de la Torre, J., Nogues, M.V., Bruix, M., Andreu, D., and Boix, E. (2011b). Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization. J. Med. Chem. 54, 7.
106. Torrent, M., Di Tommaso, P., Pulido, D., Nogués, M., Notredame, C., Boix, E., and Andreu, D. (2012). AMPA: an automated web server for prediction of protein antimicrobial regions. Bioinformatics 28, 130 -131.
107. Trulson, A., Bystrom, J., Engstrom, A., Larsson, R., and Venge, P. (2007). The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin. Exp. Allergy 37, 208 -218.
108. Ulrich, M., Petre, A., Youhnovski, N., Promm, F., Schirle, M., Schumm, M., Pero, R.S., Doyle, A., Checkel, J., Kita, H., et al. (2008). Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J. Biol. Chem. 283, 28629 -28640.
109. Venge, P., Roxin, L.E., and Olsson, I. (1977). Radioimmunoassay of human eosinophil cationic protein. Br. J. Haematol. 37, 331 -335.
110. Venge, P., Stromberg, A., Braconier, J.H., Roxin, L.E., and Olsson, I. (1978). Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins. Br. J. Haematol. 38, 475 -483.
111. Venge, P., Bystrom, J., Carlson, M., Hakansson, L., Karawacjzyk, M., Peterson, C., Seveus, L., and Trulson, A. (1999). Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin. Exp. Allergy 29, 1172 -1186.
112. Waters, L.S., Taverne, J., Tai, P.C., Spry, C.J.F., Targett, G.A.T., and Playfair, J.H.L. (1987). Killing of Plasmodium falciparum by eosinophil secretory products. Infect. Immun. 55, 877 -881.
113. Woschnagg, C., Rubin, J., and Venge, P. (2009). Eosinophil cationic protein (ECP) is processed during secretion. J. Immunol. 183, 3949 -3954.
114. Zanetti, M., Gennaro, R., and Romeo, D. (1995). Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374, 1 -5.
115. Zanfardino, A., Pizzo, E., Di Maro, A., Varcamonti, M., and D'Alessio, G. (2010). The bactericidal action on Escherichia coli of ZF-RNase-3 is triggered by the suicidal action of the bacterium OmpT protease. FEBS J. 277, 1921 -1928.
116. Zhang, J., Rosenberg, H.F., and Nei, M. (1998). Positive Darwinian selection after gene duplication in primate ribonuclease genes. Proc. Natl. Acad. Sci. USA 95, 3708 -3713.
117. Zhang, J., Dyer, K.D., and Rosenberg, H.F. (2002). RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. Nucleic Acids Res. 30, 1169 -1175.
118. Zhang, J., Dyer, K.D., and Rosenberg, H.F. (2003). Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res. 31, 602 -607.